A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Financial flexibility is valuable, but it’s not everything - at StockStory, we help you find the stocks that can not only survive but also outperform. Keeping that in mind, here are two companies with net cash positions that balance growth with stability and one that may struggle.
One Stock to Sell:
Progyny (PGNY)
Net Cash Position: $214.4 million (14.2% of Market Cap)
Pioneering a data-driven approach to family building that has achieved an industry-leading patient satisfaction score of +80, Progyny (NASDAQ: PGNY) provides comprehensive fertility and family building benefits solutions to employers, helping employees access quality fertility treatments and support services.
Why Does PGNY Fall Short?
- Underwhelming unit sales over the past two years show it’s struggled to increase its sales volumes and had to rely on price increases
- Modest revenue base of $1.31 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Below-average returns on capital indicate management struggled to find compelling investment opportunities
At $27.95 per share, Progyny trades at 13.9x forward P/E. To fully understand why you should be careful with PGNY, check out our full research report (it’s free).
Two Stocks to Watch:
Molina Healthcare (MOH)
Net Cash Position: $1.22 billion (11.9% of Market Cap)
Founded in 1980 as a provider for underserved communities in Southern California, Molina Healthcare (NYSE: MOH) provides managed healthcare services primarily to low-income individuals through Medicaid, Medicare, and Marketplace insurance programs across 21 states.
Why Does MOH Stand Out?
- 13.7% annual revenue growth over the last five years surpassed the sector average as its offerings resonated with customers
- Economies of scale give it fixed cost leverage when sales grow as well as negotiating power over membership pricing and reimbursement rates
Molina Healthcare’s stock price of $196.88 implies a valuation ratio of 27.4x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
Axos Financial (AX)
Net Cash Position: $39.48 million (0.7% of Market Cap)
Originally founded as Bank of Internet USA in 1999 before rebranding in 2018, Axos Financial (NYSE: AX) is a diversified financial services company that provides digital banking, securities clearing, and investment advisory solutions to retail and business customers nationwide.
Why Do We Love AX?
- Annual net interest income growth of 18.3% over the past five years was outstanding, reflecting market share gains this cycle
- Differentiated product suite leads to a best-in-class net interest margin of 4.8%
- Share repurchases over the last five years enabled its annual earnings per share growth of 18.8% to outpace its revenue gains
Axos Financial is trading at $100.07 per share, or 1.6x forward P/B. Is now the right time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
